arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

EXOZYMES INC.

EXOZ

$4.57 ▲ +0.13 (+2.93%) at close

15 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

EXOZYMES INC. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $39.6M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -63.9% ↗

FCF / Share $-0.19 →

Trailing P/E —

Price / Book 11.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

15-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-2.37M

↓ -27.7% —

FCF / Share Free cash flow per share

$-0.19

↓ -1.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
EPS Growth YoY (%)	-17.9% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-24.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-37.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-38.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-237.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-27.7% Weak ↑ Weak Improving Year-over-year change in net income	-27.7% Weak ↑ Weak Improving Year-over-year change in net income	-44.6% Weak ↑ Weak Improving Year-over-year change in net income	-84.1% Weak ↓ Weak Declining Year-over-year change in net income	-84.1% Weak ↑ Weak Improving Year-over-year change in net income	-84.1% Weak ↑ Weak Improving Year-over-year change in net income	-67.1% Weak Weak Year-over-year change in net income	-318.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-34.4% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
FCF / Net Income (x)	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	3.22x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	2.55x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.13x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	-63.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-123.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	35.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	58.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	63.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	202.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-51.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-37.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-59.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-45.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-27.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-64.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-532%)	-155.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1134%)	-78.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-621%)	-34.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-25.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-20.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-17.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	28.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+87%)	44.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+197%)	80.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+438%)	285.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1806%)	-39.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Interest Coverage (x)	-1661.36x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1204.93x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1235.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1060.64x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-36.10x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-5.65M	$-1.44M	$-3.04M	$-5.10M	$-6.99M	$-8.51M	$-9.72M	$-233.94K	—	—	$-66.53K	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Basic EPS, GAAP (USD)	$-0.33	$-0.28	$-0.31	$-0.27	$-0.28	$-0.22	$-0.25	$-0.27	$-0.22	$-0.16	$-0.18	$-0.08	—	—	—
Free Cash Flow per Share (USD)	$-0.19	$-0.19	—	$-0.22	—	$-0.14	—	—	$-0.41	$0.02	—	—	—	—	—
Book Value per Share (USD)	$0.39	$0.18	$0.40	$0.64	$0.86	$1.06	$1.25	$-0.58	$-0.36	$-0.20	$-0.06	$0.10	—	—	—
Tangible Book Value per Share (USD)	$0.39	$0.18	$0.40	$0.64	$0.86	$1.06	$1.25	$-0.58	$-0.36	$-0.20	$-0.06	$0.10	—	—	—
Basic Weighted Avg Shares (shares)	8.66M	8.46M	—	8.39M	8.38M	8.37M	—	6.25M	6.25M	6.25M	—	6.25M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$4.55M	$507.58K	$2.37M	$4.37M	$6.31M	$7.97M	$9.49M	$-4.38M	—	—	$-1.20M	—	—	—	—
Total Equity (USD)	$3.65M	$1.53M	$3.40M	$5.37M	$7.24M	$8.88M	$10.42M	$-3.60M	$-2.26M	$-1.25M	$-384.32K	$607.14K	$1.07M	$1.19M	$1.37M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	$-700.00	—	—	—	—
Depreciation Expense (USD)	$76.95K	$74.15K	$73.60K	$71.60K	—	$70.50K	$67.57K	$68.88K	$68.14K	$62.79K	$58.97K	$49.72K	—	—	—
Net Income, GAAP (USD)	$-2.37M	$-2.37M	$-2.66M	$-1.86M	$-1.86M	$-1.86M	$-1.84M	$-1.01M	$-1.01M	$-1.01M	$-1.10M	$-241.15K	—	—	—
Operating Cash Flow (USD)	$-1.64M	$-1.52M	$-1.97M	$-1.86M	—	$-1.13M	$-5.71M	—	$-2.54M	$281.20K	$-783.28K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 15 quarters

EXOZYMES INC.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare EXOZ with peers